|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.40 EUR | -0.17% |
|
+1.36% | -8.85% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-10 | Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 94.28 | +24.82% | 23 | ||||||
| 1,292.53 | +4.92% | 27 | ||||||
| 272.5 | +4.08% | 22 | ||||||
| 274.36 | +10.64% | 28 | ||||||
| 370.31 | -0.75% | 18 | ||||||
| 154.14 | -1.64% | 21 | ||||||
| 211.65 | +30.55% | 22 | ||||||
| 381.59 | -8.54% | 29 | ||||||
| 314.37 | +2.68% | 24 | ||||||
| 157.41 | +18.3% | 27 | ||||||
| 28.64 | +5.89% | 26 | ||||||
| 563.08 | +7.48% | 25 | ||||||
| 66.21 | +2.11% | 24 | ||||||
| 21.61 | +12.13% | 20 | ||||||
| 9,513.33 | +33.76% | 15 | ||||||
| 6,387.69 | +14.43% | 16 | ||||||
| 56.81 | +15.39% | 18 | ||||||
| 80.33 | +48.27% | 15 | ||||||
| 4.208 | +15.23% | 17 | ||||||
| 41.2 | +14% | 10 | ||||||
| Average | 1,014.31 | +12.69% | 21 | ||||||
| Weighted average by Cap. | 710.15 | +7.60% | 24 |
- Stock Market
- Stocks
- SAN Stock
- Sector Sanofi
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
